Research Report: HIMS

Analysis Date: 2025-12-13T00:11:12.000632 Trading Period: 2025-12-08 to 2025-12-19

Company Overview

Company: Hims & Hers Health, Inc. Sector: Healthcare | Industry: Drug Manufacturers - Specialty & Generic Current Price: $37.21 Market Cap: $8,470,800,896 Beta: 2.41 Avg Volume: 26,153,296 P/E Ratio: 70.21 Website: https://www.hims.com

Description: Hims & Hers Health, Inc. operates a telehealth platform that connects consumers to licensed healthcare professionals in the United States, the United Kingdom, Canada, and internationally. The company offers a range of curated prescription and non-prescription health and wellness products and services available to purchase on its websites and mobile application directly by customers. It also provides prescription medication on a recurring basis and ongoing care from healthcare providers; and over...

Trading Recommendation

Action: STRONG AVOID Confidence: 20.0/100 Position Size: 0.0% of portfolio

Rationale: Unfavorable conditions (composite: 22.6/100, risk: EXTREME, red flags: 6).

Key Risks:

Screening Status

Passed Filters: ✓ Yes Notes: Passed all screening filters

Quantitative Analysis

Composite Score: 2.80/5.0 Percentile Rank: 50%

Factor Scores:

Technical Analysis

Setup Score: 0/8 Setup Notes:

Price Levels:

Momentum & Volume:

Risk Assessment

Risk Level: EXTREME Confidence: 10.0/100 Total Red Flags: 6 Earnings Risk: No

Critical Issues:

Market Red Flags:

Stock-Specific Red Flags:


This report is generated by PM automated research system. Always perform your own due diligence before trading.